Assessing the needs of pharmacists and physicians in caring for patients with epilepsy.

J. W. McAuley, D. A. Mott, J. C. Schommer, J. L. Moore, A. L. Reeves

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

OBJECTIVE: To obtain primary care physicians' and community pharmacists' opinions of the Pharmacist Note, a model epilepsy patient profile maintained by the pharmacist and transmitted to the physician as needed, and the information it contains. DESIGN: A cross-sectional descriptive study design was used for collecting and analyzing data. Separate surveys were developed and mailed to physicians and pharmacists. PARTICIPANTS: 554 primary care physicians and 114 community pharmacists in Ohio who interact regularly with epilepsy patients. MAIN OUTCOME MEASURES: Pharmacist and physician opinions on the Pharmacist Note program. RESULTS: Physicians ranked seizure frequency as their most useful piece of information, followed by medication compliance and drug interaction screening. For medication profile and drug interaction screening, most physicians currently use themselves as their primary source of information, although a significant number would prefer to use pharmacists as information sources in these areas (p < .05). A majority (62%) would like to have pharmacists more involved in the care of their patients. Pharmacists identified lack of time and lack of appointments with patients, inadequate pharmacy staff, and insufficient reimbursement as barriers to implementing the Pharmacist Note program. CONCLUSION: Physicians desire pharmacist involvement in specific areas of care for patients with epilepsy, and the feasibility of implementing the Pharmacist Note and similar programs appears promising. However, pharmacists identified barriers to implementation, and these barriers need to be addressed if this type of program is to be successful.

Original languageEnglish (US)
Pages (from-to)499-504
Number of pages6
JournalJournal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Volume39
Issue number4
DOIs
StatePublished - 1999

Bibliographical note

Funding Information:
Partial support for this project was provided by The Ohio State UniYenry General Clinical Research Center (Grant #M01-RROO34), Glaxo Wellconw. and Parke-Davis.

Fingerprint

Dive into the research topics of 'Assessing the needs of pharmacists and physicians in caring for patients with epilepsy.'. Together they form a unique fingerprint.

Cite this